Autoantibodies as predictors of disease

Journal of Clinical Investigation

Volumn 108, Issue 10, 2001, Pages 1417-1422

  Leslie, David ^a   Lipsky, Peter ^b   Louis Notkins, Abner ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; INSULIN; PROTEIN TYROSINE PHOSPHATASE; RHEUMATOID FACTOR; STEROID 21 MONOOXYGENASE; THYROID ANTIBODY;

ADRENAL DISEASE; ALLELE; ANTIBODY PRODUCTION; AUTOIMMUNITY; CELIAC DISEASE; DISEASE CLASSIFICATION; DISEASE MARKER; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; PERNICIOUS ANEMIA; PHYSICAL DISEASE; PREDICTION; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; THYROIDITIS;

EID: 0035188431     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI14452     Document Type: Review

References (46)

1. Auroandgens IA-2 and GAD in Type I (insulin-dependent) diabetes
2. Chronic autoimmune thyroiditis
3. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: Matkers of high progression to clinical Addison's disease
4. Pernicious anemia
5. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
6. Autoimmune type 1 diabetes: Resolved and unresolved issues
7. Early environmental events as a cause of IDDM. Evidence and implications
8. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study
9. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
10. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM
11. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in theit siblings. The Belgian Diabetes Registry
12. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
13. Thyroid autoimmunity
14. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
15. Thyroid failure in the elderly. Microsomol antibodies as discriminant for therapy
16. Coeliac disease
17. Interplay between genetics and the environment in the development of celiac disease: Perspectives for a healthy life
18. Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: Evidence for high diagnostic sensitivity for celiac disease
19. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease
20. Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies: The antibody trinity of coeliac disease
21. Autoantibodies to tissue transglutaminase as predictors of celiac disease
22. Serological markers for coeliac disease: Changes with time and relationship to enteropathy
23. Identification of coeliac disease in primary care
24. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease
25. DRB1 *04 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease
26. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls
27. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anaemia
28. Prevalence of undiagnosed pernicious anemia in the elderly
29. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry
30. The rheumatoid factor: An analysis of clinical utility
31. Range of antinuclear antibodies in "healthy" individuals
32. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy
33. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
34. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus
35. Antibodies to snRNPs in systemic lupus erythematosus
36. Antiribosomal antibodies in systemic lupus erythematosus
37. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study
38. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
39. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies
40. The relationship of rheumatoid serum factor to rheumatoid arthritis: A 5-year follow up of a population sample
41. When does rheumatoid disease start?
42. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study
43. Changing autoantibody profiles with variable clinical manifestations in a patient with relapsing systemic lupus erythematosus and polymyositis
44. Features of autoantigens
45. Natural history of early primary biliary cirrhosis
46. Symptom development and prognosis in primary biliary cirrhosis: A study in two centers